Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Valeant Pharmaceuticals, a developer, manufacturer and marketer of a range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics, has acquired AB Sanitas.
Subscribe to our email newsletter
Previously, Valeant signed a deal to take over Lithuania-based specialty pharmaceuticals company AB Sanitas for around EUR314m.
Sanitas has a range of branded generics product portfolio consisting of 390 products in nine countries throughout Central and Eastern Europe, primarily Poland, Russia and Lithuania.
The company has in-house development capabilities in dermatology, ophthalmology and hospital injectables and also a pipeline of internally developed and acquired dossiers.